Association between global functioning at first schizophrenia diagnosis and treatment resistance

被引:8
作者
Horsdal, Henriette T. [1 ,2 ]
Wimberley, Theresa [1 ,2 ]
Kohler-Forsberg, Ole [2 ,3 ]
Baandrup, Lone [4 ]
Gasse, Christiane [1 ,2 ,5 ]
机构
[1] Aarhus Univ, Aarhus BSS, Natl Ctr Register Based Res, Dept Econ & Business Econ, Fuglesangs Alle 4, DK-8210 Aarhus V, Denmark
[2] Lundbeck Fdn, Initiat Psychiat Res, iPSYCH, Aarhus, Denmark
[3] Aarhus Univ Hosp, Psychosis Res Unit, Risskov, Denmark
[4] Univ Copenhagen, Mental Hlth Ctr Glostrup, Ctr Neuropsychiat Schizophrenia Res, Glostrup, Denmark
[5] Aarhus Univ, Ctr Integrated Register Based Res, Aarhus, Denmark
关键词
antipsychotics; global functioning; risk factors; schizophrenia; treatment resistance; DANISH; CLOZAPINE; ANTIPSYCHOTICS; PRESCRIPTION; PREDICTORS; INDICATORS; NATIONWIDE; SCALES;
D O I
10.1111/eip.12522
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Aim: Several factors such as age, gender, urbanicity and clinical treatment setting have been associated with treatment-resistant schizophrenia (TRS). We examined the association between the Global Assessment of Functioning (social Functioning [GAF-F]) score at first schizophrenia diagnosis and TRS and explored whether level of functioning could partially explain the known associations. Methods: A nationwide population-based cohort study among individuals, who had a GAF-F score at first schizophrenia diagnosis. We used adjusted Cox regression analysis to calculate hazard ratios (HRs). Results: Among 3252 individuals, severe functional impairment (GAF-F <= 30) was associated with TRS within 2 years after diagnosis (adjusted HR = 1.38 [95% confidence interval: 1.03-1.87). GAF-F had virtually no impact on the associations between investigated known risk factors and TRS. Conclusions: GAF-F was independently associated with TRS. Consideration of a global functioning score may help clinicians to detect treatment resistance earlier among individuals with schizophrenia.
引用
收藏
页码:1198 / 1202
页数:5
相关论文
共 34 条
[1]   A Qualitative Study of Clinicians Experience with Rating of the Global Assessment of Functioning (GAF) Scale [J].
Aas, I. H. Monrad ;
Sonesson, Ove ;
Torp, Steffen .
COMMUNITY MENTAL HEALTH JOURNAL, 2018, 54 (01) :107-116
[2]  
[Anonymous], COCHRANE DATABASE SY
[3]   Explanatory model of illness of the patients with schizophrenia and the role of educational intervention [J].
Awan, Naila Riaz ;
Jehangir, Syeda Farhana ;
Irfan, Muhammad ;
Naeem, Farooq ;
Farooq, Saeed .
SCHIZOPHRENIA RESEARCH, 2017, 190 :68-73
[4]   The Danish Schizophrenia Registry [J].
Baandrup, Lone ;
Cerqueira, Charlotte ;
Haller, Lea ;
Korshoj, Lene ;
Voldsgaard, Inge ;
Nordentoft, Merete .
CLINICAL EPIDEMIOLOGY, 2016, 8 :691-695
[5]  
Baandrup Lone, 2012, Ugeskr Laeger, V174, P2548
[6]   Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology [J].
Barnes, Thomas R. E. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (05) :567-620
[7]   The importance of measuring psychosocial functioning in schizophrenia [J].
Brissos, Sofia ;
Molodynski, Andrew ;
Dias, Vasco Videira ;
Figueira, Maria Lusa .
ANNALS OF GENERAL PSYCHIATRY, 2011, 10
[8]  
Carter MJ, 2014, THER RECREAT J, V48, P275
[9]   Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones [J].
Iasevoli, Felice ;
Giordano, Sara ;
Balletta, Raffaele ;
Latte, Gianmarco ;
Formato, Maria Vittoria ;
Prinzivalli, Emiliano ;
De Berardis, Domenico ;
Tomasetti, Carmine ;
de Bartolomeis, Andrea .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2016, 65 :34-48
[10]   Danish education registers [J].
Jensen, Vibeke M. ;
Rasmussen, Astrid W. .
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2011, 39 :91-94